Results 181 to 190 of about 580,459 (300)
Analysis of Factors Influencing the Psychological State of Patients After Autologous Liver Transplantation. [PDF]
Zhang T, Fu S.
europepmc +1 more source
Summary B‐cell maturation antigen‐directed chimeric antigen receptor (CAR) T cells have revolutionized the treatment of relapsed/refractory multiple myeloma. However, no randomized head‐to‐head comparison of idecabtagene vicleucel (ide‐cel) and ciltacabtagene autoleucel (cilta‐cel) is available, and real‐world data suggest differences in efficacy and ...
Irene Strassl +23 more
wiley +1 more source
Cardio-Oncological Sequelae of Autologous Stem Cell Transplantation: Role of Clonal Hematopoiesis in Cardiovascular Risk. [PDF]
Sándor Z +7 more
europepmc +1 more source
Summary Preclinical and clinical studies suggest that selective serotonin reuptake inhibitors (SSRIs) can stimulate haematopoiesis by promoting proliferation and mobilization of haematopoietic stem and progenitor cells, but whether SSRI use influences myeloid malignancy risk remains unclear.
Katrine Mose +5 more
wiley +1 more source
Case Report: Autologous bone marrow mononuclear cell transplantation improved motor function in a patient with amyotrophic lateral sclerosis. [PDF]
Okuda M, Okinaka Y, Saino O, Taguchi A.
europepmc +1 more source
The evolution of iPSC-based cell therapy across autologous and allogeneic pathways. [PDF]
Wang A, Zhang Y, Deng H, Gu M.
europepmc +1 more source
Summary While marginal zone lymphoma (MZL) is generally indolent, outcomes following relapse remain poorly defined. This study utilized the indolent Non Follicular 10 (NF10) prospective database to characterize survival and identify prognostic drivers in patients failing initial systemic therapy. The study analysed 122 patients with relapsed MZL.
Stefano Luminari +28 more
wiley +1 more source
Engraftment Syndrome After Second Autologous Stem Cell Transplantation for Myeloma: A Case Report. [PDF]
Salveridou K +5 more
europepmc +1 more source
Higher chimeric antigen receptor‐T expansion at day 7 is associated with improved progression‐free survival but also increased toxicity in axi‐cel treated patients with R/R large B‐cell lymphoma, independent of other baseline patient and disease characteristics.
Brydon Panozzo +17 more
wiley +1 more source

